Thioacetamide → HCID 66673711, Verbindung
Reaktionsgleichung
[C:1]([NH2:4])(=[S:3])[CH3:2].Br[CH2:6][C:7]([N:9]1[CH2:14][CH2:13][N:12]([C:15]([O:17][C:18]([CH3:21])([CH3:20])[CH3:19])=[O:16])[CH2:11][CH2:10]1)=O>C(O)C>[CH3:2][C:1]1[S:3][CH:6]=[C:7]([N:9]2[CH2:14][CH2:13][N:12]([C:15]([O:17][C:18]([CH3:21])([CH3:20])[CH3:19])=[O:16])[CH2:11][CH2:10]2)[N:4]=1Komponenten
4
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
Thioacetamide (120 mg) was added to an ethanol (6 mL) solution of tert-butyl 4-(bromoacetyl)piperazinecarboxylate (340 mg) obtained in the above 1), and heated under reflux for 3 hours. The reaction liquid was restored to room temperature, then the solvent was evaporated away under reduced pressure, and the resulting residue was purified through silica gel column chromatography (hexane/ethyl acetate=7/3) to obtain 7 mg of the entitled compound.
Aufarbeitung
- customobtained in the above 1), and
- temperatureheated
- temperatureunder reflux for 3 hours
- customThe reaction liquid
- customwas restored to room temperature
- customthe solvent was evaporated away under reduced pressure
- customthe resulting residue was purified through silica gel column chromatography (hexane/ethyl acetate=7/3)
Quellen und Nachweise
- ORD-Eintrag
- ord-5049bb1cc5e24c538645131813f4771e
- Quelldatensatz
- uspto-grants-2012_01
- Patentnummer
- US08101618B2
Notizen zur Reaktion
Wird geladen…